Clicky

InnoCan Pharma Corporation(INNPF)

Description: InnoCan Pharma Corporation focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment and other viruses causing lung inflammation, as well as other central nervous system diseases, such as epilepsy and Alzheimer's disease; and CBD loaded liposomes that provides pain relief, and treat epilepsy, other central nervous system disorders, and other indications. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is headquartered in Calgary, Canada.


Keywords: Drugs Pain Organ Systems Inflammation Alzheimer's Disease E Commercial Cannabidiol Psoriasis Drug Delivery Analgesics Epilepsy Viruses Resorcinols CBD Central Nervous System Disorders Anticonvulsants Treatment Products Pharmaceutical Ingredients Central Nervous System Disease Pain Relief Serum Muscle Pain

Home Page: innocanpharma.com

1015, 926 – 5 Avenue SW
Calgary, AB T2P 0N7
Canada
Phone: 403 777 1519


Officers

Name Title
Mr. Ron Mayron Exec. Chairman
Ms. Iris Bincovich CEO & Director
Mr. Yoram Drucker Founder, Exec. VP of Bus. Devel. & Director
Mr. Nelson Harvey Halpern F.C.A., FCPA Chief Financial Officer
Mr. Nir Avram B.Sc., M.Sc. Chief Technology Officer
Mr. Eyal Flom L.L.M., M.B.A. Director & Company Sec.
Roni Kamhi Chief Operating Officer
Mr. Moshe Hukaylo Chief Financial Officer of InnoCan Pharma Ltd.

Exchange: OTCQB

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 7.1874
Price-to-Sales TTM: 39.6435
IPO Date:
Fiscal Year End: October
Full Time Employees: 0
Back to stocks